March 12, 2014—Requiring Oregon health centers to give the state all of their 340B savings on drugs for Medicaid beneficiaries, whose care is mainly managed and paid for by the state’s new Medicaid coordinated care organizations, “may not actually be effective and could adversely impact patient care,” a new study concludes.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.
Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)